ArticleNucleic acids research2021
The European Bioinformatics Institute: empowering cooperation in response to a global health crisis.
Article in Nucleic acids research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- GTDB release 10: a complete and systematic taxonomy for 715 230 bacterial and 17 245 archaeal genomes.Nucleic acids research · 2026Article
- Gut microbiota and tuberculosis.iMeta · 2025Review
- ViralPrimer: a web server to monitor viral nucleic acid amplification tests' primer efficiency during pandemics, with emphasis on SARS-CoV-2 and Mpox.Bioinformatics (Oxford, England) · 2024Article
- An Inflammatory Bowel Diseases Integrated Resources Portal (IBDIRP).Database : the journal of biological databases and curation · 2024Article
- Idbview: a database and interactive platform for respiratory-associated disease.Frontiers in immunology · 2024Article
- Putting everything in its place: using the INSDC compliant Pathogen Data Object Model to better structure genomic data submitted for public health applications.Microbial genomics · 2023Article
- Introduction of the Korea BioData Station (K-BDS) for sharing biological data.Genomics & informatics · 2023Article
- Scientists without borders: lessons from Ukraine.GigaScience · 2022Article
- Genomic analysis of sewage from 101 countries reveals global landscape of antimicrobial resistance.Nature communications · 2022Article
- Identification of mutations in SARS-CoV-2 PCR primer regions.Scientific reports · 2022Article
- Revised eutherian gene collections.BMC genomic data · 2022Article
- GTDB: an ongoing census of bacterial and archaeal diversity through a phylogenetically consistent, rank normalized and complete genome-based taxonomy.Nucleic acids research · 2022Article
- The European Bioinformatics Institute (EMBL-EBI) in 2021.Nucleic acids research · 2022Article
- Data Mining, Quality and Management in the Life Sciences.Methods in molecular biology (Clifton, N.J.) · 2022Article
- The International Human Genome Project.Human molecular genetics · 2021Review
- CovidExpress: an interactive portal for intuitive investigation on SARS-CoV-2 related transcriptomes.bioRxiv : the preprint server for biology · 2021Article
- The Genome Sequence Archive Family: Toward Explosive Data Growth and Diverse Data Types.Genomics, proteomics & bioinformatics · 2021Article
- GenoVault: a cloud based genomics repository.BioData mining · 2021Article
- The 2021 Nucleic Acids Research database issue and the online molecular biology database collection.Nucleic acids research · 2021Article
- The European Nucleotide Archive in 2020.Nucleic acids research · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The European Bioinformatics Institute (EMBL-EBI; https://www.ebi.ac.uk/) provides freely available data and bioinformatics services to the scientific community, alongside its research activity and training provision. The 2020 COVID-19 pandemic has brought to the forefront a need for the scientific community to work even more cooperatively to effectively tackle a global health crisis. EMBL-EBI has been able to build on its position to contribute to the fight against COVID-19 in a number of ways. Firstly, EMBL-EBI has used its infrastructure, expertise and network of international collaborations to help build the European COVID-19 Data Platform (https://www.covid19dataportal.org/), which brings together COVID-19 biomolecular data and connects it to researchers, clinicians and public health professionals. By September 2020, the COVID-19 Data Platform has integrated in excess of 170 000 COVID-19 biomolecular data and literature records, collected through a number of EMBL-EBI resources. Secondly, EMBL-EBI has strived to continue its support of the life science communities through the crisis, with updated Training provision and improved service provision throughout its resources. The COVID-19 pandemic has highlighted the importance of EMBL-EBI's core principles, including international cooperation, resource sharing and central data brokering, and has further empowered scientific cooperation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.